Fractalkine (CX3CL1) stimulated by nuclear factor κB (NF-κB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway

Biochemical Journal

Volumn 373, Issue 2, 2003, Pages 547-558

  Chandrasekar, Bysani ^a   Mummidi, Srinivas ^a   Perla, Rao P ^a   Bysani, Sailaja ^a   Dulin, Nickolai O ^b   Liu, Feng ^a   Melby, Peter C ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Atherosclerosis; Autoregulation; Cell adhesion; CX3C receptor 1 (CX3CR1); Fractalkine (CX3CL1); Mitosis; Nuclear factor B (NF B)

Indexed keywords

ADHESION; DISEASES; PROTEINS;

MUSCLE CELLS;

CELLS;

CHEMOKINE; CYTOKINE; DNA; FRACTALKINE; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PERTUSSIS TOXIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL ADHESION; CELL DEATH; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; INFLAMMATION; MITOSIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; ANTINEOPLASTIC AGENTS; AORTA; AUTOCRINE COMMUNICATION; CELL DIVISION; CELLS, CULTURED; CHEMOKINES, CX3C; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME INHIBITORS; GTP-BINDING PROTEINS; I-KAPPA B PROTEINS; LUCIFERASES; MEMBRANE PROTEINS; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; PROLINE; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTORS, CYTOKINE; RECEPTORS, HIV; RNA, MESSENGER; THIOCARBAMATES; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 6; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0041845203     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20030207     Document Type: Article

References (49)

1. Libby, P. (2002) Inflammation in atherosclerosis. Nature (London) 420, 868-874
2. Onuffer, J J. and Horuk, R. (2002) Chemokines, chemokine receptors and small-molecule antagonists: recent developments. Trends Pharmacol. Sci. 23, 459-467
3. Rossi, D. and Zlotnik, A. (2000) The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217-242
4. Terkeltaub, R., Boisvert, W. A. and Curtiss, L. K. (1998) Ohemokines and atherosclerosis. Curr. Opin. Lipidol. 9, 397-405
5. Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A. and Schall, T. J. (1997) A new class of membrane-bound chemokine with a CX3C motif. Nature (London) 385, 640-644
6. Fong, A. M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T. and Patel, D. D. (1998) Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 188, 1413-1419
7. Garton, K. J., Gough, P. J., Blobel, C. P., Murphy, G., Greaves, D. R., Dempsey, P. J. and Raines, E. W. (2001) Tumor necrosis factor-α-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J. Biol. Chem. 276, 37993-38001
8. Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M, Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J. and Yoshie, O. (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell (Cambridge, Mass.) 91, 521-530
9. Garcia, G. E, Xia, Y., Chen, S., Wang, Y., Ye, R. D., Harrison, J. K., Bacon, K. B., Zerwes, H. G. and Feng, L. (2000) NF-κB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1β, TNF-α, and LPS. J. Leukocyte Biol. 67, 577-584
10. Harrison, J. K., Jiang, Y., Wees, E. A., Salafranca, M. N., Liang, H. X., Feng, L. and Belardinelli, L. (1999) inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart. J. Leukocyte Biol. 66, 937-944
11. Ludwig, A., Berkhout, T., Moores, K., Greet, P. and Chapman, G. (2002) Fractalkine is expressed by smooth muscle cells in response to IFN-γ and TNF-α and is modulated by metalloproteinase activity. J. Immunol. 168, 604-512
12. Orlov, S. N., Tremblay, J. and Hamet, P. (1996) cAMP signaling inhibits dihydropyridine-sensitive Ca2+ influx in vascular smooth muscle cells. Hypertension 27, 774-780
13. Hu, Y., Qiao, L., Wang, S., Rong, S.-b., Meuillet, E. J., Berggren, M., Gallegos, A., Powis, G. and Kozikowski, A. P. (2000) 3-(hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth. J. Med. Chem. 43, 3045-3051
14. Corda, S., Laplace, C., Vicaut, E. and Duranteau, J. (2001) Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-α is mediated by ceramide. Am. J. Respir. Cell Mol. Biol. 24, 762-768
15. Han, Y., He, T., Huang, D. R., Pardo, C. A. and Ransohoff, R. M. (2001) TNF-α mediates SDF-1α-induced NF-κB activation and cytotoxic effects in primary astrocytes. J. Clin. Invest. 108, 425-435
16. Mayne, M., Ni, W., McKenna, R. and Power, C. (1999) Antisense oligodeoxynucleotides targeting internal exon sequences efficiently regulate TNF-α expression. Antisense Nucleic Acid Drug Dev. 9, 135-144
17. Chandrasekar, B., Smith, J. B. and Freeman, G. L. (2001) Ischemia-reperfusion of rat myocardium activates nuclear factor-κB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 103, 2296-2302
18. + CXC chemokine LIX (CXCL5) amplifies a proinfiammatory cytokine response via a phosphatidylinositol 3-kinase-NF-κB pathway. J. Biol. Chem. 278, 4675-4686
19. Wick, M. J., Dong, L. Q., Riojas, R. A. Ramos, F. J. and Liu, F. (2000) Mechanism of phosphorylation of protein kinase B/Akt by a constitutively active 3-phosphoinositide-dependent protein kinase-1. J. Biol. Chem. 275, 40400-40406
20. Dulin, N. O., Sorokin, A., Reed, E., Elliott, S., Kehrl, J. H. and Dunn, M. J. (1999) RGS3 inhibits G protein-mediated signaling via translocation to the membrane and binding to Gα11. Mol. Cell Biol. 19, 714-723
21. Niu, J., Scheschonka, A., Druey, K. M., Davis, A., Reed, E., Kolenko, V., Bodnar, R., Voyno-Yasenetskaya, T., Du, X., Kehrl, J. and Dulin, N. O. (2002) RGS3 interacts with 14-13-3 via the N-terminal region distinct from the RGS (regulator of G-protein signalling) domain Biochem. J. 365, 677-684.
22. 2 induce IL-18 and IL-18Rβ expression in cardiomyocytes via NFκ-B activation. Biochem. Biophys. Res. Commun. 303, 1152-1158
23. Chandrasekar, B., Mitchell, D. H., Colston, J. T. and Freeman, G. L. (1999) Regulation of COAAT/Enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia/reperfusion. Circulation 99, 427-433
24. Murray, D. R., Prabhu, S. D. and Chandrasekar, B. (2000) Chronic β-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 101, 2338-2341
25. Foukas, L. C., Daniele, N., Ktori, C., Anderson, K. E., Jensen, J. and Shepherd, P. R. (2002) Direct effects of caffeine and theophylline on p1108 and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities. J. Biol. Chem. 277, 37124-37130
26. Cadwallader, K. A., Condliffe, A. M., McGregor, A., Walker, T. R., White, J. F., Stephens, L. R. and Chilvers, E. R. (2002) Regulation of phosphatidylinositol 3-kinase activity and phosphatidylinositol 3,4,5-trisphosphate accumulation by neutrophil priming agents. J. Immunol. 169, 3336-3344
27. Pollman, M. J., Yamada, T., Horiuchi, M. and Gibbons, G. H. (1996) Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ. Res. 79, 748-756
28. Braut-Boucher, F., Pichon, J., Rat, P., Adolphe, M., Aubery, M. and Font, J. (1995) A non-isotopic, highly sensitive, fiuorimetric, cell-adhesion microplate assay using calcein AM-labeled lymphocytes. J. Immunol. Methods. 178, 41-51
29. Choe, N., Zhang, J., Iwagaki, A., Tanaka, S., Hemenway, D. R. and Kagan, E. (1999) Asbestos exposure upregulates the adhesion of pleural leukocytes to pleural mesothelial cells via VCAM-1. Am. J. Physiol. 277, L292-L300
30. Baud, V. and Karin, M. (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11, 372-377
31. Cao, Z., Tanaka, M., Regnier, C., Rothe, M., Yamit-hezi, A., Woronicz, J. D., Fuentes, M. E., Durnin, M. H., Dalrymple, S. A. and Goeddel, D. V. (1999) NF-κB activation by tumor necrosis factor and interleukin-1. Cold Spring Harbor Symp. Quant. Biol. 64, 473-483
32. Ozes, O. N., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M. and Donner, D. B. (1999) NF-κ B activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature (London) 401, 82-85
33. Toker, A. and Cantley, L. C. (1997)) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature (London) 387, 673-676
34. Datta, S. R., Brunet, A. and Greenberg, M. E. (1999) Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927
35. Druey, K. M., Blumer, K. J., Kang, V. H. and Kehrl, J. H. (1996) Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature (London) 379, 742-746
36. L and pro-apoptotic activity. J. Biol. Chem. 272, 24101-24104
37. L. Cell (Cambridge, Mass.) 8'7, 619-628
38. Umehara, H., Bloom, E., Okazaki, T., Domae, N. and Imai, T. (2001) Fractalkine and vascular injury. Trends Immunol. 22, 602-607
39. Tartaglia, L. and Goeddel, D. (1992) Two TNF receptors. Immunol. Today 13, 151-153
40. Idriss, H. T. and Naismith, J. H. (2000) TNF and the TNF receptor superfamily: structure-function relationship(s). Microsc. Res. Tech. 50, 184-195
41. Schreck, R., Meier, B., Mannel, D. N., Droge, W. and Baeuerle, P. A. (1992) Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175, 1181-1194
42. Meng, F., Liu, L., Chin, P. C. and D'Mello, S. R. (2002) Akt is a downstream target of NF-κB. J. Biol. Chem. 2'77, 29674-29680
43. Inngjerdingen, M., Damaj, B., Maghazachi, A. A. (2001) Expression and regulation of chemokine receptors in human natural killer cells. Blood 97, 367-375
44. Meucci, O., Fatatis, A., Simen, A. A. and Miller, R. J. (2000) Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. U.S.A. 97, 8075-8080
45. Fong, A. M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T. and Patel, D. D. (1998) Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 188, 1413-1419
46. Wong, B. W., Wong, D. and McManus, B. M. (2002) Characterization of tractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovasc. Pathol. 11, 332-338
47. Faure, S., Meyer, L., Costagliola, D., Vaneensberghe, C., Genin, E., Autran, B., Delfraissy, J. F., McDermott, D. H., Murphy, P. M., Debre, P. et al. (2000) Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science (Washington, D.C.) 287, 2274-2277
48. McDermott, D. H., Halcox, J. P., Schenke, W. H., Waclawiw, M. A., Merrell, M. N., Epstein, N., Quyyumi, A. A. and Murphy, P. M. (2001) Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ. Res. 89, 401-407
49. Moatti, D., Faure, S., Fumeron, F., Amara, M.-W., Seknadji, P., McDermott, D. H., Debre, P., Aumont, M. C., Murphy, P. M., de Prost, D. and Combadiere, C. (2001) Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97, 1925-1928